Teva Pharmaceuticals invented a state-of-the-art asthma inhaler that utilizes breath-activated technology to help patients know how often and how well they use their inhaler, as measured by inspiratory flow. Objective data is collected through a smartphone app and stored in the cloud. The data may then be shared with doctors for more informed treatment decisions. The client asked our team for a campaign exploration that would make it easy to understand the benefits of the Digihaler system for patients and doctors.